Echocardiographic monitoring of patients with heart failure.
Twenty seven patients diagnosed as having systolic heart failure with Ejection Fraction (EF) of less than 40% by echocardiography were monitored over a period of 3 years. The monitored parameters included clinical symptoms, diastolic dysfunction, therapies and survival during three years of treatment. The results indicate a beneficial effect of treatment with high doses of ACE-inhibitors, spironolactone and beta-blockers in improving clinical symptoms and diastolic function. The survival rate was similar to that in the developed European countries.
Macić-Dzanković
Amra
A
Department of Cardiology, General Hospital "Prim. dr Abdulah Nakas", Kranjcevićeva 12, 71000 Sarajevo, Bosnia and Herzegovina.
Dzanković
Fuad
F
Pojskić
Belma
B
Skopljak
Amira
A
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D002309:Cardiology / Q000379:methods; D003971:Diastole; D004452:Echocardiography / Q000379:methods*; D006333:Heart Failure / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008991:Monitoring, Physiologic; D013148:Spironolactone / Q000008:administration & dosage; D013599:Systole; D013997:Time Factors; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D013148:Spironolactone